Çakıroğlu, E. Et Al. 2017. The Role of Morus Nigra Extract and Its Active Compounds as Drug Candidate on Human Colorectal Adenocarcinoma Cell Line HT-29. International Journal of Clinical Oncology and Cancer Research , vol.2, no.1 , 10-14.

Çakıroğlu, E., UYSAL KILIÇ, T., ÇALIBAŞI KOÇAL, G., AYGENLİ, F., BARAN, G., & BAŞBINAR, Y., (2017). The Role of Morus Nigra Extract and Its Active Compounds as Drug Candidate on Human Colorectal Adenocarcinoma Cell Line HT-29. International Journal of Clinical Oncology and Cancer Research , vol.2, no.1, 10-14.

Çakıroğlu, Ece Et Al. "The Role of Morus Nigra Extract and Its Active Compounds as Drug Candidate on Human Colorectal Adenocarcinoma Cell Line HT-29," International Journal of Clinical Oncology and Cancer Research , vol.2, no.1, 10-14, 2017

Çakıroğlu, Ece Et Al. "The Role of Morus Nigra Extract and Its Active Compounds as Drug Candidate on Human Colorectal Adenocarcinoma Cell Line HT-29." International Journal of Clinical Oncology and Cancer Research , vol.2, no.1, pp.10-14, 2017

Çakıroğlu, E. Et Al. (2017) . "The Role of Morus Nigra Extract and Its Active Compounds as Drug Candidate on Human Colorectal Adenocarcinoma Cell Line HT-29." International Journal of Clinical Oncology and Cancer Research , vol.2, no.1, pp.10-14.

@article{article, author={Ece Çakıroğlu Et Al. }, title={The Role of Morus Nigra Extract and Its Active Compounds as Drug Candidate on Human Colorectal Adenocarcinoma Cell Line HT-29}, journal={International Journal of Clinical Oncology and Cancer Research}, year=2017, pages={10-14} }